Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Overview

Journal Curr Neuropharmacol

Publisher Bentham Science Publishers

Date 2021 Feb 16

PMID 33588732

Citations 6

Authors

Syed Sayeed Ahmad

Mohammad Khalid

Mohammad A Kamal

Kaiser Younis

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) affects several people worldwide and has devastating impacts on society with a limited number of approaches for its pharmacological treatment. The main causes of AD are not clear yet. However, the formation of senile plaques, neurofibrillary tangles, hyper-phosphorylation of tau protein, and disruption of redox homeostasis may cause AD. These causes have a positive correlation with oxidative stress, producing reactive ions, which are responsible for altering the physiological condition of the body.

Conclusion: Ongoing research recommended the use of phytochemicals as acetylcholinesterase inhibitors to hinder the onset and progression of AD. The natural compound structures, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids have anti-inflammatory, antioxidant, and anti-amyloidogenic properties. The purpose of this article is to provide a brief introduction to AD along with the use of natural compounds as new therapeutic approaches for its management.

Citing Articles

Beneficial Effects of Extracts and Sideridiol against Amyloid β Toxicity.

Gioran A, Paikopoulos Y, Panagiotidou E, Rizou A, Nasi G, Dimaki V Antioxidants (Basel). 2024; 13(3).

PMID: 38539796 PMC: 10967505. DOI: 10.3390/antiox13030261.

Therapeutic Applications of Ginseng Natural Compounds for Health Management.

Ahmad S, Ahmad K, Hwang Y, Lee E, Choi I Int J Mol Sci. 2023; 24(24).

PMID: 38139116 PMC: 10744087. DOI: 10.3390/ijms242417290.

3D QSAR based Virtual Screening of Flavonoids as Acetylcholinesterase Inhibitors.

Andole S, Sd H, Sudhula S, Vislavath L, Boyina H, Gangarapu K Adv Exp Med Biol. 2023; 1424:233-240.

PMID: 37486499 DOI: 10.1007/978-3-031-31982-2_26.

, inflammation and prion protein binding.

Forloni G, La Vitola P, Balducci C Front Neurosci. 2022; 16:822420.

PMID: 36081661 PMC: 9445368. DOI: 10.3389/fnins.2022.822420.

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease.

Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J Molecules. 2022; 27(13).

PMID: 35807418 PMC: 9268689. DOI: 10.3390/molecules27134175.

References

Schliebs R, Liebmann A, Bhattacharya S, Kumar A, Ghosal S, Bigl V . Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997; 30(2):181-90. DOI: 10.1016/s0197-0186(96)00025-3. View

Zhang Q, Chen C, Wang F, Li C, Zhang Q, Hu Y . Simultaneous screening and analysis of antiplatelet aggregation active alkaloids from Rhizoma Corydalis. Pharm Biol. 2016; 54(12):3113-3120. DOI: 10.1080/13880209.2016.1211714. View

AnjiReddy K, Karpagam S . Chitosan nanofilm and electrospun nanofiber for quick drug release in the treatment of Alzheimer's disease: In vitro and in vivo evaluation. Int J Biol Macromol. 2017; 105(Pt 1):131-142. DOI: 10.1016/j.ijbiomac.2017.07.021. View

Ali B, Jamal Q, Shams S, Al-Wabel N, Siddiqui M, Alzohairy M . In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment. CNS Neurol Disord Drug Targets. 2016; 15(5):624-8. DOI: 10.2174/1871527315666160321110607. View

Marques L, Maada I, de Kanter F, Lingeman H, Irth H, Niessen W . Stability-indicating study of the anti-Alzheimer's drug galantamine hydrobromide. J Pharm Biomed Anal. 2011; 55(1):85-92. DOI: 10.1016/j.jpba.2011.01.022. View

Wilson B, Samanta M, Santhi K, Sampath Kumar K, Ramasamy M, Suresh B . Significant delivery of tacrine into the brain using magnetic chitosan microparticles for treating Alzheimer's disease. J Neurosci Methods. 2008; 177(2):427-33. DOI: 10.1016/j.jneumeth.2008.10.036. View

Whittaker V . The contribution of drugs and toxins to understanding of cholinergic function. Trends Pharmacol Sci. 1990; 11(1):8-13. DOI: 10.1016/0165-6147(90)90034-6. View

Huo X, Zhang Y, Jin X, Li Y, Zhang L . A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease. J Photochem Photobiol B. 2018; 190:98-102. DOI: 10.1016/j.jphotobiol.2018.11.008. View

Silman I, Sussman J . Acetylcholinesterase: how is structure related to function?. Chem Biol Interact. 2008; 175(1-3):3-10. DOI: 10.1016/j.cbi.2008.05.035. View

10.

de Oliveira J, Abdalla F, Dornelles G, Adefegha S, Palma T, Signor C . Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer's-like dementia: Involvement of acetylcholinesterase and cell death. Neurotoxicology. 2016; 57:241-250. DOI: 10.1016/j.neuro.2016.10.008. View

11.

Brownstein M . A brief history of opiates, opioid peptides, and opioid receptors. Proc Natl Acad Sci U S A. 1993; 90(12):5391-3. PMC: 46725. DOI: 10.1073/pnas.90.12.5391. View

12.

Stackman R, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn J . Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol. 2003; 184(1):510-20. DOI: 10.1016/s0014-4886(03)00399-6. View

13.

Mahaman Y, Huang F, Wu M, Wang Y, Wei Z, Bao J . Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments. J Alzheimers Dis. 2018; 63(3):1141-1159. PMC: 6004908. DOI: 10.3233/JAD-180091. View

14.

Xie J, Brayne C, Matthews F . Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ. 2008; 336(7638):258-62. PMC: 2223023. DOI: 10.1136/bmj.39433.616678.25. View

15.

Ilhan A, Gurel A, Armutcu F, Kamisli S, Iraz M, Akyol O . Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain. Clin Chim Acta. 2004; 340(1-2):153-62. DOI: 10.1016/j.cccn.2003.10.012. View

16.

Spence J, Chintapenta M, Kwon H, Blaszczyk A . A Brief Review of Three Common Supplements Used in Alzheimer's Disease. Consult Pharm. 2017; 32(7):412-414. DOI: 10.4140/TCP.n.2017.412. View

17.

Meng F, Wu Z, Yin Z, Lin L, Wang R, Zhang Q . Coptidis rhizoma and its main bioactive components: recent advances in chemical investigation, quality evaluation and pharmacological activity. Chin Med. 2018; 13:13. PMC: 5842587. DOI: 10.1186/s13020-018-0171-3. View

18.

Elmegeed G, Ahmed H, Hashash M, Abd-Elhalim M, El-Kady D . Synthesis of novel steroidal curcumin derivatives as anti-Alzheimer's disease candidates: Evidences-based on in vivo study. Steroids. 2015; 101:78-89. DOI: 10.1016/j.steroids.2015.06.003. View

19.

Mazumder U, Gupta M, Chakrabarti S, Pal D . Evaluation of hematological and hepatorenal functions of methanolic extract of Moringa oleifera Lam. root treated mice. Indian J Exp Biol. 2000; 37(6):612-4. View

20.

Wilson B, Samanta M, Santhi K, Kumar K, Ramasamy M, Suresh B . Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine. 2009; 6(1):144-52. DOI: 10.1016/j.nano.2009.04.001. View